ERBB2 and neoplasm: As NAC induces antitumor immune activation for specific populations, including patients with luminal, TN, and HER-2-positive breast cancers, the activated tumor-specific immune response may eradicate residual tumor cells and contribute to the curing of breast cancer in these patients.